PUBLISHER: Grand View Research | PRODUCT CODE: 1888835
PUBLISHER: Grand View Research | PRODUCT CODE: 1888835
The global DNA sequencing market size was estimated at USD 14.88 billion in 2024 and is projected to reach USD 91.88 billion by 2033, growing at a CAGR of 22.66% from 2025 to 2033. The market's steady growth is driven by rising adoption of next generation sequencing technologies, increasing clinical applications in oncology and rare disease diagnostics, and expanding investments in genomics research globally.
Increasing Adoption of DNA Vaccines
The market for DNA sequencing is seeing a sharp increase in demand due to the growing use of DNA vaccines. High-precision sequencing is essential to the design, validation, and optimization of plasmid constructs encoding antigenic proteins in DNA vaccine development. To ensure proper gene insertion, confirm plasmid integrity, and identify potential mutations during the manufacturing process, sequencing is crucial.
Next-generation sequencing (NGS) is crucial for verifying the genetic stability and purity of large-scale DNA vaccine production, which also requires strict quality control and adherence to regulatory compliance. Sequencing-based workflows for preclinical validation, immunogenicity assessment, and safety profiling have become increasingly popular among developers due to the global shift toward faster vaccine development, which pandemic preparedness initiatives have accelerated.
Global DNA Sequencing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the DNA sequencing market on the basis of product & services, technology, workflow, application, end use, and region.